ArticleJAMA network open2026

Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer.

Pedro C Barata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.